Moderna
MRNA
#1164
Rank
NZ$33.84 B
Marketcap
NZ$85.34
Share price
-0.87%
Change (1 day)
84.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -NZ$4.73 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$1.92 Billion. , an increase over its 2024 earnings that were of -NZ$6.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$4.83 Billion-23.03%
2024 -NZ$6.27 Billion-8.22%
2023 -NZ$6.84 Billion-140.65%
2022 NZ$16.80 B-27.81%
2021 NZ$23.27 B-1911.15%
2020 -NZ$1.29 Billion44.7%
2019 -NZ$0.89 Billion28.63%
2018 -NZ$0.7 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$58.71 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.61 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$39.23 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-NZ$83 Million-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$73.08 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.00 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$0.60 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA